Percentage Change in Body Weight The mean on-treatment change in body weight was 5.9% (95% CI, 6.0% to 5.8%) for tirzepatide vs 3.6% (95% CI, 3.7% to 3.4%) for semaglutide at 3 months, 10.1% (95% CI, 10.4% to 9.9%) vs 5.8% (95% CI, 6.0% to 5.5%) at 6 months, and 15.3% (95% CI, 16.0% to 14.5%) vs 8.3% (95% CI, 9% to 7.6%) at 12 months (Figure 4)
STROBE Initiative
However, the absence of documented cases does not definitively exclude the possibility of an association, particularly given the relatively recent widespread use of semaglutide
These side effects are typically transient and diminish as the body adjusts to the peptide during the initial 4-week phase
Al comparar catlogos, la variedad marca la diferencia: tragamonedas con funciones especiales, botes progresivos, ruleta en vivo con presentadores profesionales, blackjack con reglas claras y pker con mesas de distintos lmites
1400 N